6th Annual Structure Based Drug Design

Dedicated Focus on Computational Kinase
Pre-Conference Short Course: Wednesday, June 14th
Designing Structure-Based Kinase Inhibitors

http://www.healthtech.com/2006/sbd/

Conference Highlights:
Pre-Conference Short Course: Designing Structure-Based Kinase Inhibitors NEW!

Cutting-Edge Sessions from Industry Leaders

Hot Topic Sessions on Fragment-Based Drug Discovery NEW!

Panel Discussion: How Much More Effective will Drug Discovery Become NEW!
in the Next 10 Years?

Case Studies from Abbott Laboratories and Wyeth Research NEW!

And much more!

Hear from Industry Leaders Including:
Peter Fedichev, Ph.D., Corporate Scientific Officer, Quantum Pharmaceuticals

William L. Jorgensen, Ph.D., Whitehead Professor of Chemistry, Department of
Chemistry, Yale University

Dr. Mario Lobell, Computational Chemistry, Bayer HealthCare, Germany

Klaus Müller, Ph.D., Pharmaceutical Research-Head of Science & Technology
Relations, F. Hoffmann-La Roche Ltd.

Mark Murcko, Ph.D., Vice President and Chief Technology Officer, Vertex
Pharmaceuticals, Inc.

Christopher Murray, Ph.D., Director, Computational Chemistry and Informatics,
Astex Therapeutics

Leszek Poppe, Ph.D., Principle Scientist, Molecular Structure Department, Amgen,
Inc.

Tomi K. Sawyer, Ph.D., Senior Vice President, Drug Discovery, ARIAD
Pharmaceuticals

Robert A. Voldmann, Ph.D., Senior Research Fellow, Pfizer Global Research and
Development

And many more!

For more information, please contact:
Shelley W. Amster, Conference Director
617-630-1373 samster@healthtech.com

For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
617-630-1352 scarroll@healthtech.com